Osteopenia (Disorder) Unknown Status Phase 2 / 3 Trials for Alendronic acid (DB00630)

Also known as: Osteopenia / Osteopenia (morphologic abnormality) / Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0087613 (Osteopenia (Disorder))Unknown Status2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00209469Network Osteoporosis StudyTreatment